Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected: Proceedings of the jubilee Twenty-Fifth International Symposium on Blood Transfusion, Groningen, 2000, Organized by the Sanquin Division Blood Bank Noord Nederland / Edition 1by Cees Smit Sibinga
Transfusion Medicine is the proceedings of the 25th Jubilee International Symposium on Blood Transfusion and reviews what has been achieved and what can be expected. There have been many achievements during the last quarter of the 20th century - for example the Landsteiner discovery of red cell markers and the Huestin development of an appropriate anticoagulant.… See more details below
Transfusion Medicine is the proceedings of the 25th Jubilee International Symposium on Blood Transfusion and reviews what has been achieved and what can be expected. There have been many achievements during the last quarter of the 20th century - for example the Landsteiner discovery of red cell markers and the Huestin development of an appropriate anticoagulant.
The proceedings of this landmark symposium offer a wealth of information on the future of this new and evolving field of medicine. The material is presented in four sections: Blood Supply Systems and Organisation; Technical and Pharmaceutical Developments; Quality Principles and Risk Management; and Transfusion Medicine for the Patient.
Transfusion Medicine provides a comprehensive review of this area and its accomplishments and future directions. This is a worthwhile and recommended edition for those involved in transfusion medicine: clinicians, policy makers, and researchers.
- Springer US
- Publication date:
- Developments in Hematology and Immunology (closed) Series, #36
- Edition description:
- Product dimensions:
- 9.21(w) x 6.14(h) x 0.75(d)
Table of Contents
Moderators and Speakers. Foreword. I: Blood Supply Systems and Organisation. Blood Transfusion: Quo Vadis? Customer Orientation as the Leading Principal for Blood Banks in the Future; Th.E.P. Lotgerink. Community Involvement: The Development, the Past - the Present and the Future of Blood Donations as a Form of Community Involvement; A.P.M. Los. Structure and Commitments - Blood Supply Systems and Organization; J.C. Emmanuel. Applying Decision Analysis to Transfusion Medicine in the Real World to Improve Transfusion Safety; J.P. AuBuchon. Cost-Effectiveness of HIV NAT Screening for Dutch Donors; M.J. Postma. Legal and Regulatory Aspects of Blood Transfusion; M.L. Kavanagh. Discussion. II: Technical and Pharmaceutical Developments. Freezing and Vitrification of Red Cells, Recollections and Predictions; H.T. Meryman. Plasma Fractionation; P.R. Foster. Viral Marker Screening: Is More Resting Safer? J.-P. Allain. Inactivation of Viruses, Bacteria, Protozoa, and Leukocytes in Labile Blood Components by Using Nucleic Acid Targeted Methods; L.M. Corash. Alternatives to Human Blood Resources; P.M. Ness. Discussion. III: Quality Principles and Risk Management. Quality Systems and Management: 2000. Where Have we Been and Where are we Going? K. Sazama. Traceability and Coding Principles; J. Koistinen. Quality Principles and Risk Management: Automation and Documentation; M. Bruce. Haemovigilance; N. Drouet. Human Resources: Teaching and Training in Transfusion Medicine; J.F. Harrison. Discussion. IV: Transfusion Medicine at the Bedside. The Epidemiology of Blood Component Transfusion in South Eastern Scotland, 1990 to 1997; D.B.L. McClelland. Contributions of Meta-Analysis to Transfusion Medicine; E.C. Vamvakas. Immunomodulation: Facts and Interpretations; A. Brand. Development and Implementation of New Cellular Therapies; J. McCullough. Transfusion Medicine and the Development of Gene Therapy; M.L. Turner. Making Policy in the 2000s; J.C. Emmanuel. Discussion. Index.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >